Bank of America’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-624
Closed -$3K 8046
2014
Q4
$3K Hold
624
﹤0.01% 7455
2014
Q3
$4K Sell
624
-320
-34% -$3.16K ﹤0.01% 7656
2014
Q2
$14K Buy
+944
New +$16.4K ﹤0.01% 7342

Other funds holding RCPI

Bank of America's RCPI Position: Q4 2015 in Review

Bank of America sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 580 shares.

Bank of America first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $350K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Bank of America reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Bank of America sold 580 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
  • Bank of America first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
  • Bank of America's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $350K in Q2 2014.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.